Condition: Clinical Stage II to III Non-Small Cell Lung Cancer · Sponsor: Yonsei University
1. To explore tissue-based biomarkers to select patients who do not respond to neoadjuvant immunotherapy (non-responders) at the point of diagnosis 2. To explore blood-based non-invasive biomarkers to predict pathological complete response (pCR) before surgery
This description comes directly from the study's public registry record.
Tae Hee Hong · (82)10-3487-6255 · thhongcs@yuhs.ac
Always discuss trial participation with your own doctor first.
| Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06907160